Cite

HARVARD Citation

    Eggermont, A. et al. (2020). Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model. European journal of cancer. pp. 11-18. [Online]. 
  
Back to record